BeOne Medicines
ONC
#532
Rank
A$68.43 B
Marketcap
A$599.15
Share price
-0.97%
Change (1 day)
7.16%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2026 (TTM): A$11.85

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is A$12.28. In 2025 the company made an earnings per share (EPS) of A$4.09 an increase over its 2024 EPS that were of A-$9.35.

EPS history for BeOne Medicines from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$11.85189.6%
2025A$4.09-143.75%
2024A-$9.35
2022A-$29.2328.21%
2021A-$22.80-19.96%
2020A-$28.4920.81%
2019A-$23.5831.52%
2018A-$17.93417.57%
2017A-$3.46-37.16%
2016A-$5.51158.95%
2015A-$2.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
A-$0.28-102.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
A-$1.42-111.60%๐Ÿ‡บ๐Ÿ‡ธ USA